{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["N-heterocycles", "anticancer", "derivatives", "hybrids", "oleanolic acid", "pentacyclic triterpenoids"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33918996", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "26"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "21"}], "Language": ["eng"], "ELocationID": ["2401", "10.3390/molecules26092401"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "9", "PubDate": {"Year": "2021", "Month": "Apr", "Day": "21"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery.", "Abstract": {"AbstractText": ["Pentacyclic triterpenoids are well-known phytochemicals with various biological activities commonly found in plants as secondary metabolites. The wide range of biological activities exhibited by triterpenoids has made them the most valuable sources of pharmacological agents. A number of novel triterpenoid derivatives with many skeletal modifications have been developed. The most important modifications are the formation of analogues or derivatives with nitrogen-containing heterocyclic scaffolds. The derivatives with nitrogen-containing heterocyclic compounds are among the most promising candidate for the development of novel therapeutic drugs. About 75% of FDA-approved drugs are nitrogen-containing heterocyclic moieties. The unique properties of heterocyclic compounds have encouraged many researchers to develop new triterpenoid analogous with pharmacological activities. In this review, we discuss recent advances of nitrogen-containing heterocyclic triterpenoids as potential therapeutic agents. This comprehensive review will assist medicinal chemists to understand new strategies that can result in the development of compounds with potential therapeutic efficacy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Fort Hare, Alice Campus, Alice 5700, Eastern Cape, South Africa."}], "LastName": "Khwaza", "ForeName": "Vuyolwethu", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Fort Hare, Alice Campus, Alice 5700, Eastern Cape, South Africa."}], "LastName": "Mlala", "ForeName": "Sithenkosi", "Initials": "S"}, {"Identifier": ["0000-0002-1240-3718"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Fort Hare, Alice Campus, Alice 5700, Eastern Cape, South Africa."}], "LastName": "Oyedeji", "ForeName": "Opeoluwa O", "Initials": "OO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Fort Hare, Alice Campus, Alice 5700, Eastern Cape, South Africa."}], "LastName": "Aderibigbe", "ForeName": "Blessing A", "Initials": "BA"}], "GrantList": [{"GrantID": "SAMRC", "Agency": "South African Medical Research Council", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Heterocyclic Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Pentacyclic Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Triazoles"}, {"RegistryNumber": "N762921K75", "NameOfSubstance": "Nitrogen"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Discovery"}, {"QualifierName": ["chemistry"], "DescriptorName": "Heterocyclic Compounds"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nitrogen"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Pentacyclic Triterpenes"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemistry"], "DescriptorName": "Triazoles"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alves-Silva J.M., Romane A., Efferth T., Salgueiro L. North African medicinal plants traditionally used in cancer therapy. Front. Pharmacol. 2017;8:383. doi: 10.3389/fphar.2017.00383.", "ArticleIdList": ["10.3389/fphar.2017.00383", "PMC5483438", "28694778"]}, {"Citation": "Tariq A., Sadia S., Pan K., Ullah I., Mussarat S., Sun F., Abiodun O.O., Batbaatar A., Li Z., Song D., et al. A systematic review on ethnomedicines of anti-cancer plants. Phyther. Res. 2017;31:202\u2013264. doi: 10.1002/ptr.5751.", "ArticleIdList": ["10.1002/ptr.5751", "28093828"]}, {"Citation": "Singh S., Sharma B., Kanwar S.S., Kumar A. Lead phytochemicals for anticancer drug development. Front. Plant Sci. 2016;7:1667. doi: 10.3389/fpls.2016.01667.", "ArticleIdList": ["10.3389/fpls.2016.01667", "PMC5099879", "27877185"]}, {"Citation": "Sharma H., Kumar P., Deshmukh R.R., Bishayee A., Kumar S. Pentacyclic triterpenes: New tools to fight metabolic syndrome. Phytomedicine. 2018;50:166\u2013177. doi: 10.1016/j.phymed.2018.09.011.", "ArticleIdList": ["10.1016/j.phymed.2018.09.011", "30466975"]}, {"Citation": "Borkov\u00e1 L., Frydrych I., Jakubcov\u00e1 N., Ad\u00e1mek R., Li\u0161kov\u00e1 B., Gursk\u00e1 S., Medved\u00edkov\u00e1 M., Hajd\u00fach M., Urban M. Synthesis and biological evaluation of triterpenoid thiazoles derived from betulonic acid, dihydrobetulonic acid, and ursonic acid. Eur. J. Med. Chem. 2020;185:111806. doi: 10.1016/j.ejmech.2019.111806.", "ArticleIdList": ["10.1016/j.ejmech.2019.111806", "31677446"]}, {"Citation": "Kamble S.M., Goyal S.N., Patil C.R. Multifunctional pentacyclic triterpenoids as adjuvants in cancer chemotherapy: A review. RSC Adv. 2014;4:33370\u201333382. doi: 10.1039/C4RA02784A.", "ArticleIdList": ["10.1039/C4RA02784A"]}, {"Citation": "Herrera-Espa\u00f1a A.D., Us-Mart\u00edn J., Hern\u00e1ndez-Ortega S., Mir\u00f3n-L\u00f3pez G., Quijano L., Villanueva-Toledo J.R., Mena-Rej\u00f3n G.J. Synthesis, structure analysis and activity against breast and cervix cancer cells of a triterpenoid thiazole derived from ochraceolide A. J. Mol. Struct. 2020;1204:127555. doi: 10.1016/j.molstruc.2019.127555.", "ArticleIdList": ["10.1016/j.molstruc.2019.127555"]}, {"Citation": "Han B., Peng Z. Anti-HIV triterpenoid components. J. Chem. Pharm. Res. 2014;6:438\u2013443."}, {"Citation": "Medina-O\u2019Donnell M., Rivas F., Reyes-Zurita F.J., Cano-Mu\u00f1oz M., Martinez A., Lupia\u00f1ez J.A., Parra A. Oleanolic Acid Derivatives as Potential Inhibitors of HIV-1 Protease. J. Nat. Prod. 2019;82:2886\u20132896. doi: 10.1021/acs.jnatprod.9b00649.", "ArticleIdList": ["10.1021/acs.jnatprod.9b00649", "31617361"]}, {"Citation": "Kaur R., Sharma P., Gupta G.K., Ntie-Kang F., Kumar D. Structure-activity-relationship and mechanistic insights for anti-HIV natural products. Molecules. 2020;25:2070. doi: 10.3390/molecules25092070.", "ArticleIdList": ["10.3390/molecules25092070", "PMC7249135", "32365518"]}, {"Citation": "Bednarczyk-Cwynar B., Wachowiak N., Szulc M., Kami\u0144ska E., Bogacz A., Bartkowiak-Wieczorek J., Zaprutko L., Mikolajczak P.L. Strong and long-lasting antinociceptive and anti-inflammatory conjugate of naturally occurring oleanolic acid and aspirin. Front. Pharmacol. 2016;7:202. doi: 10.3389/fphar.2016.00202.", "ArticleIdList": ["10.3389/fphar.2016.00202", "PMC4940421", "27462270"]}, {"Citation": "Fukumitsu S., Villareal M.O., Fujitsuka T., Aida K., Isoda H. Anti-inflammatory and anti-arthritic effects of pentacyclic triterpenoids maslinic acid through NF-\u03baB inactivation. Mol. Nutr. Food Res. 2016;60:399\u2013409. doi: 10.1002/mnfr.201500465.", "ArticleIdList": ["10.1002/mnfr.201500465", "26499467"]}, {"Citation": "Prachayasittikul S., Saraban P., Cherdtrakulkiat R., Ruchirawat S., Prachayasittikul V. New bioactive triterpenoids and antimalarial activity of Diospyros rubra Lec. EXCLI J. 2010;9:1.", "ArticleIdList": ["PMC5698898", "29255382"]}, {"Citation": "Wang G.W., Deng L.Q., Luo Y.P., Liao Z.H., Chen M. Hepatoprotective triterpenoids and lignans from the stems of Schisandra pubescens. Nat. Prod. Res. 2017;31:1855\u20131860. doi: 10.1080/14786419.2016.1261348.", "ArticleIdList": ["10.1080/14786419.2016.1261348", "27871187"]}, {"Citation": "Xu G.B., Xiao Y.H., Zhang Q.Y., Zhou M., Liao S.G. Hepatoprotective natural triterpenoids. Eur. J. Med. Chem. 2018;145:691\u2013716. doi: 10.1016/j.ejmech.2018.01.011.", "ArticleIdList": ["10.1016/j.ejmech.2018.01.011", "29353722"]}, {"Citation": "Chung P.Y. Novel targets of pentacyclic triterpenoids in Staphylococcus aureus: A systematic review. Phytomedicine. 2020;73:152933. doi: 10.1016/j.phymed.2019.152933.", "ArticleIdList": ["10.1016/j.phymed.2019.152933", "31103429"]}, {"Citation": "Spivak A.Y., Khalitova R.R., Nedopekina D.A., Gubaidullin R.R. Antimicrobial properties of amine-and guanidine-functionalized derivatives of betulinic, ursolic and oleanolic acids: Synthesis and structure/activity evaluation. Steroids. 2020;154:108530. doi: 10.1016/j.steroids.2019.108530.", "ArticleIdList": ["10.1016/j.steroids.2019.108530", "31678136"]}, {"Citation": "Beinke C., Scherthan H., Port M., Popp T., Hermann C., Eder S. Triterpenoid CDDO-Me induces ROS generation and up-regulates cellular levels of antioxidative enzymes without induction of DSBs in human peripheral blood mononuclear cells. Radiat. Environ. Biophys. 2020;59:461\u2013472. doi: 10.1007/s00411-020-00847-w.", "ArticleIdList": ["10.1007/s00411-020-00847-w", "PMC7369132", "32409897"]}, {"Citation": "Choi C.W., Jung H.A., Kang S.S., Choi J.S. Antioxidant constituents and a new triterpenoid glycoside from Flos Lonicerae. Arch. Pharm. Res. 2007;30:1. doi: 10.1007/BF02977770.", "ArticleIdList": ["10.1007/BF02977770", "17328234"]}, {"Citation": "Banerjee S., Bose S., Mandal S.C., Dawn S., Sahoo U., Ramadan M.A., Mandal S.K. Pharmacological Property of Pentacyclic Triterpenoids. Egypt. J. Chem. 2019;62:13\u201335. doi: 10.21608/ejchem.2019.16055.1975.", "ArticleIdList": ["10.21608/ejchem.2019.16055.1975"]}, {"Citation": "Csuk R. Betulinic acid and its derivatives: A patent review (2008\u20132013) Expert Opin. Ther. Pat. 2014;24:913\u2013923. doi: 10.1517/13543776.2014.927441.", "ArticleIdList": ["10.1517/13543776.2014.927441", "24909232"]}, {"Citation": "Cao J., Zhang X., Qu F., Guo Z., Zhao Y. Dammarane triterpenoids for pharmaceutical use: A patent review (2005\u20132014) Expert Opin. Ther. Pat. 2015;25:805\u2013817. doi: 10.1517/13543776.2015.1038239.", "ArticleIdList": ["10.1517/13543776.2015.1038239", "25892194"]}, {"Citation": "Kashyap D., Sharma A., Tuli H.S., Punia S., Sharma A.K. Ursolic acid and oleanolic acid: Pentacyclic terpenoids with promising anti-inflammatory activities. Recent Pat. Inflamm. Allergy Drug Discov. 2016;10:21\u201333. doi: 10.2174/1872213X10666160711143904.", "ArticleIdList": ["10.2174/1872213X10666160711143904", "27531153"]}, {"Citation": "Sporn M.B., Liby K.T., Gribble G.W., Honda T., Kral R.M., Meyer C.J. Dartmouth College and Reata Pharmaceuticals Inc. Synthetic Triterpenoids and Methods of Use in the Treatment of Disease. 8,129,429. U.S. Patent. 2012 Mar 06;"}, {"Citation": "Yan X.J., Gong L.H., Zheng F.Y., Cheng K.J., Chen Z.S., Shi Z. Triterpenoids as reversal agents for anticancer drug resistance treatment. Drug Discov. Today. 2014;19:482\u2013488. doi: 10.1016/j.drudis.2013.07.018.", "ArticleIdList": ["10.1016/j.drudis.2013.07.018", "23954181"]}, {"Citation": "Kvasnica M., Urban M., Dickinson N.J., Sarek J. Pentacyclic triterpenoids with nitrogen-and sulfur-containing heterocycles: Synthesis and medicinal significance. Nat. Prod. Rep. 2015;32:1303\u20131330. doi: 10.1039/C5NP00015G.", "ArticleIdList": ["10.1039/C5NP00015G", "26030604"]}, {"Citation": "Zhou M., Zhang R.H., Wang M., Xu G.B., Liao S.G. Prodrugs of triterpenoids and their derivatives. Eur. J. Med. Chem. 2017;131:222\u2013236. doi: 10.1016/j.ejmech.2017.03.005.", "ArticleIdList": ["10.1016/j.ejmech.2017.03.005", "28329729"]}, {"Citation": "Kerru N., Bhaskaruni S.V., Gummidi L., Maddila S.N., Maddila S., Jonnalagadda S.B. Recent advances in heterogeneous catalysts for the synthesis of imidazole derivatives. Synth. Commun. 2019;49:2437\u20132459. doi: 10.1080/00397911.2019.1639755.", "ArticleIdList": ["10.1080/00397911.2019.1639755"]}, {"Citation": "Kalaria P.N., Karad S.C., Raval D.K. A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery. Eur. J. Med. Chem. 2018;158:917\u2013936. doi: 10.1016/j.ejmech.2018.08.040.", "ArticleIdList": ["10.1016/j.ejmech.2018.08.040", "30261467"]}, {"Citation": "World Health Organisation  Internation Agency for Research on Cancer.  [(accessed on 8 October 2020)];2018  Available online:  https://www.who.int/cancer/PRGlobocanFinal.pdf."}, {"Citation": "Khotimchenko M. Pectin polymers for colon-targeted antitumor drug delivery. Int. J. Biol. Macromol. 2020;158:1110\u20131124. doi: 10.1016/j.ijbiomac.2020.05.002.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.05.002", "32387365"]}, {"Citation": "Rodrigues F.C., Kumar N.A., Thakur G. Developments in the anticancer activity of structurally modified curcumin: An up-to-date review. Eur. J. Med. Chem. 2019;177:76\u2013104. doi: 10.1016/j.ejmech.2019.04.058.", "ArticleIdList": ["10.1016/j.ejmech.2019.04.058", "31129455"]}, {"Citation": "Khwaza V., Oyedeji O.O., Aderibigbe B.A. Ursolic acid-based derivatives as potential anti-cancer agents: An update. Int. J. Mol. Sci. 2020;21:5920. doi: 10.3390/ijms21165920.", "ArticleIdList": ["10.3390/ijms21165920", "PMC7460570", "32824664"]}, {"Citation": "Selvam C., Prabu S.L., Jordan B.C., Purushothaman Y., Umamaheswari A., Zare M.S.H., Thilagavathi R. Molecular mechanisms of curcumin and its analogs in colon cancer prevention and treatment. Life Sci. 2019;239:117032. doi: 10.1016/j.lfs.2019.117032.", "ArticleIdList": ["10.1016/j.lfs.2019.117032", "31704450"]}, {"Citation": "Babalola I.T., Shode F.O. Ubiquitous ursolic acid: A potential pentacyclic triterpene natural product. J. Pharmacogn. Phytochem. 2013;2:214\u2013222."}, {"Citation": "Khwaza V., Oyedeji O.O., Aderibigbe B.A. Antiviral activities of oleanolic acid and its analogues. Molecules. 2018;23:2300. doi: 10.3390/molecules23092300.", "ArticleIdList": ["10.3390/molecules23092300", "PMC6225463", "30205592"]}, {"Citation": "Dzubak P., Hajduch M., Vydra D., Hustova A., Kvasnica M., Biedermann D., Markova L., Urban M., Sarek J. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat. Prod. Rep. 2006;23:394\u2013411. doi: 10.1039/b515312n.", "ArticleIdList": ["10.1039/b515312n", "16741586"]}, {"Citation": "Shanmugam M.K., Nguyen A.H., Kumar A.P., Tan B.K., Sethi G. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer. Cancer Lett. 2012;320:158\u2013170. doi: 10.1016/j.canlet.2012.02.037.", "ArticleIdList": ["10.1016/j.canlet.2012.02.037", "22406826"]}, {"Citation": "Smith P.F., Ogundele A., Forrest A., Wilton J., Salzwedel K., Doto J., Allaway G.P., Martin D.E. Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3\u2032,3\u2032-dimethylsuccinyl) betulinic acid (bevirimat) against human immunodeficiency virus infection. Antimicrob. Agents Chemother. 2007;51:3574\u20133581. doi: 10.1128/AAC.00152-07.", "ArticleIdList": ["10.1128/AAC.00152-07", "PMC2043264", "17638699"]}, {"Citation": "Dang Z., Ho P., Zhu L., Qian K., Lee K.H., Huang L., Chen C.H. New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1. J. Med. Chem. 2013;56:2029\u20132037. doi: 10.1021/jm3016969.", "ArticleIdList": ["10.1021/jm3016969", "PMC3600082", "23379607"]}, {"Citation": "Xu H., Ji L., Yu C., Chen Q., Ge Q., Lu Y. MiR-423-5p Regulates Cells Apoptosis and Extracellular Matrix Degradation via Nucleotide-Binding, Leucine-Rich Repeat Containing X1 (NLRX1) in Interleukin 1 beta (IL-1\u03b2)-Induced Human Nucleus Pulposus Cells. Med. Sci. Monit. 2020;26:e922497. doi: 10.12659/MSM.922497.", "ArticleIdList": ["10.12659/MSM.922497", "PMC7254941", "32467560"]}, {"Citation": "Manu K.A., Kuttan G. Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-\u03baB mediated activation of bcl-2 in B16F-10 melanoma cells. Int. Immunopharmacol. 2008;8:974\u2013981. doi: 10.1016/j.intimp.2008.02.013.", "ArticleIdList": ["10.1016/j.intimp.2008.02.013", "18486908"]}, {"Citation": "Pengyue Z., Tao G., Hongyun H., Liqiang Y., Yihao D. Breviscapine confers a neuroprotective efficacy against transient focal cerebral ischemia by attenuating neuronal and astrocytic autophagy in the penumbra. Biomed. Pharmacother. 2017;90:69\u201376. doi: 10.1016/j.biopha.2017.03.039.", "ArticleIdList": ["10.1016/j.biopha.2017.03.039", "28343073"]}, {"Citation": "Byun H.S., Zhou W., Park I., Kang K., Lee S.R., Piao X., Park J.B., Kwon T.K., Na M., Hur G.M. C-27-carboxylated oleanane triterpenoids up-regulate TRAIL DISC assembly via p38 MAPK and CHOP-mediated DR5 expression in human glioblastoma cells. Biochem. Pharmacol. 2018;158:243\u2013260. doi: 10.1016/j.bcp.2018.10.019.", "ArticleIdList": ["10.1016/j.bcp.2018.10.019", "30359578"]}, {"Citation": "Wang W., Zhao C., Jou D., L\u00fc J., Zhang C., Lin L., Lin J. Ursolic acid inhibits the growth of colon cancer-initiating cells by targeting STAT3. Anticancer Res. 2013;33:4279\u20134284.", "ArticleIdList": ["24122993"]}, {"Citation": "El Bourakadi K., Mekhzoum M.E.M., Saby C., Morjani H., Chakchak H., Merghoub N., Bouhfid R. Synthesis, characterization and in vitro anticancer activity of thiabendazole-derived 1, 2, 3-triazole derivatives. New J. Chem. 2020;44:12099\u201312106. doi: 10.1039/C9NJ05685H.", "ArticleIdList": ["10.1039/C9NJ05685H"]}, {"Citation": "Pokhodylo N., Shyyka O., Matiychuk V. Synthesis and anticancer activity evaluation of new 1, 2, 3-triazole-4-carboxamide derivatives. Med. Chem. Res. 2014;23:2426\u20132438. doi: 10.1007/s00044-013-0841-8.", "ArticleIdList": ["10.1007/s00044-013-0841-8"]}, {"Citation": "Louie T., Goodman C.D., Holloway G.A., McFadden G.I., Mollard V., Watson K.G. Dimeric cyclohexane-1, 3-dione oximes inhibit wheat acetyl-CoA carboxylase and show anti-malarial activity. Bioorg. Med. Chem. Lett. 2010;20:4611\u20134613. doi: 10.1016/j.bmcl.2010.06.007.", "ArticleIdList": ["10.1016/j.bmcl.2010.06.007", "20580556"]}, {"Citation": "Batra N., Rajendran V., Wadi I., Lathwal A., Dutta R.K., Ghosh P.C., Gupta R.D., Nath M. Synthesis, characterization, and antiplasmodial efficacy of sulfonamide-appended [1,2,3]-triazoles. J. Heterocycl. Chem. 2020;57:1625\u20131636. doi: 10.1002/jhet.3888.", "ArticleIdList": ["10.1002/jhet.3888"]}, {"Citation": "Tan W., Li Q., Wang H., Liu Y., Zhang J., Dong F., Guo Z. Synthesis, characterization, and antibacterial property of novel starch derivatives with 1, 2, 3-triazole. Carbohydr. Polym. 2016;142:1\u20137. doi: 10.1016/j.carbpol.2016.01.007.", "ArticleIdList": ["10.1016/j.carbpol.2016.01.007", "26917366"]}, {"Citation": "Nejadshafiee V., Naeimi H., Zahraei Z. Efficient synthesis and antibacterial evaluation of some substituted \u03b2-hydroxy-1, 2, 3-triazoles. Chem. Data Collect. 2020;28:100443. doi: 10.1016/j.cdc.2020.100443.", "ArticleIdList": ["10.1016/j.cdc.2020.100443"]}, {"Citation": "Dai Z., Chen Y., Zhang M., Li S., Yang T., Shen L., Wang J., Qian S., Zhu H., Ye Y. Synthesis and Antifungal Activity of 1,2,3-Triazole Phenylhydrazone Derivatives. Org. Biomol. Chem. 2015;13:10715\u201310722. doi: 10.1039/C4OB01758G.", "ArticleIdList": ["10.1039/C4OB01758G", "25374053"]}, {"Citation": "Aher N.G., Pore V.S., Mishra N.N., Kumar A., Shukla P.K., Sharma A., Bhat M.K. Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues. Bioorg. Med. Chem. Lett. 2009;19:759\u2013763. doi: 10.1016/j.bmcl.2008.12.026.", "ArticleIdList": ["10.1016/j.bmcl.2008.12.026", "19110424"]}, {"Citation": "Chandrika K.M., Sharma S. Promising antifungal agents: A minireview. Bioorganic Med. Chem. 2020;28:115398. doi: 10.1016/j.bmc.2020.115398.", "ArticleIdList": ["10.1016/j.bmc.2020.115398", "32115335"]}, {"Citation": "Cheng C.Y., Haque A., Hsieh M.F., Imran Hassan S., Faizi M., Haque S., Dege N., Khan M.S. 1, 4-Disubstituted 1H-1,2,3-Triazoles for renal diseases: Studies of viability, anti-inflammatory, and antioxidant activities. Int. J. Mol. Sci. 2020;21:3823. doi: 10.3390/ijms21113823.", "ArticleIdList": ["10.3390/ijms21113823", "PMC7312092", "32481556"]}, {"Citation": "He Y.W., Dong C.Z., Zhao J.Y., Ma L.L., Li Y.H., Aisa H.A. 1,2,3-Triazole-containing derivatives of rupestonic acid: Click-chemical synthesis and antiviral activities against influenza viruses. Eur. J. Med. Chem. 2014;76:245\u2013255. doi: 10.1016/j.ejmech.2014.02.029.", "ArticleIdList": ["10.1016/j.ejmech.2014.02.029", "24583605"]}, {"Citation": "Cao X., Wang W., Wang S., Bao L. Asymmetric synthesis of novel triazole derivatives and their in vitro antiviral activity and mechanism of action. Eur. J. Med. Chem. 2017;139:718\u2013725. doi: 10.1016/j.ejmech.2017.08.057.", "ArticleIdList": ["10.1016/j.ejmech.2017.08.057", "28858766"]}, {"Citation": "Xu Z., Zhao S.J., Liu Y. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships. Eur. J. Med. Chem. 2019;183:111700. doi: 10.1016/j.ejmech.2019.111700.", "ArticleIdList": ["10.1016/j.ejmech.2019.111700", "31546197"]}, {"Citation": "Thi T.A.D., Tuyet N.T.K., The C.P., Nguyen H.T., Thi C.B., Phuong H.T., Van Boi L., Van Nguyen T., D\u2019hooghe M. Synthesis and cytotoxic evaluation of novel amide\u2013triazole-linked triterpenoid\u2013AZT conjugates. Tetrahedron Lett. 2015;56:218\u2013224."}, {"Citation": "Thi T.A.D., Tuyet N.T.K., The C.P., Nguyen H.T., Thi C.B., Duy T.D., D\u2019hooghe M., Van Nguyen T. Synthesis and cytotoxic evaluation of novel ester-triazole-linked triterpenoid\u2013AZT conjugates. Bioorg. Med. Chem. 2014;24:5190\u20135194.", "ArticleIdList": ["25442310"]}, {"Citation": "Majeed R., Sangwan P.L., Chinthakindi P.K., Khan I., Dangroo N.A., Thota N., Hamid A., Sharma P.R., Saxena A.K., Koul S. Synthesis of 3-O-propargylated betulinic acid and its 1,2,3-triazoles as potential apoptotic agents. Eur. J. Med. Chem. 2013;63:782\u2013792. doi: 10.1016/j.ejmech.2013.03.028.", "ArticleIdList": ["10.1016/j.ejmech.2013.03.028", "23584541"]}, {"Citation": "Khan I., Guru S.K., Rath S.K., Chinthakindi P.K., Singh B., Koul S., Bhushan S., Sangwan P.L. A novel triazole derivative of betulinic acid induces extrinsic and intrinsic apoptosis in human leukemia HL-60 cells. Eur. J. Med. Chem. 2016;108:104\u2013116. doi: 10.1016/j.ejmech.2015.11.018.", "ArticleIdList": ["10.1016/j.ejmech.2015.11.018", "26629862"]}, {"Citation": "Suman P., Patel A., Solano L., Jampana G., Gardner Z.S., Holt C.M., Jonnalagadda S.C. Synthesis and cytotoxicity of Baylis-Hillman template derived betulinic acid-triazole conjugates. Tetrahedron. 2017;73:4214\u20134226. doi: 10.1016/j.tet.2016.11.056.", "ArticleIdList": ["10.1016/j.tet.2016.11.056"]}, {"Citation": "Shi W., Tang N., Yan W.D. Synthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry. J. Asian Nat. Prod. Res. 2015;17:159\u2013169. doi: 10.1080/10286020.2014.979164.", "ArticleIdList": ["10.1080/10286020.2014.979164", "25379995"]}, {"Citation": "Sidova V., Zoufaly P., Pokorny J., Dzubak P., Hajduch M., Popa I., Urban M. Cytotoxic conjugates of betulinic acid and substituted triazoles prepared by Huisgen Cycloaddition from 30-azidoderivatives. PLoS ONE. 2017;12:0171621. doi: 10.1371/journal.pone.0171621.", "ArticleIdList": ["10.1371/journal.pone.0171621", "PMC5291411", "28158265"]}, {"Citation": "Chakraborty B., Dutta D., Mukherjee S., Das S., Maiti N.C., Das P., Chowdhury C. Synthesis and biological evaluation of a novel betulinic acid derivative as an inducer of apoptosis in human colon carcinoma cells (HT-29) Eur. J. Med. Chem. 2015;102:93\u2013105. doi: 10.1016/j.ejmech.2015.07.035.", "ArticleIdList": ["10.1016/j.ejmech.2015.07.035", "26248310"]}, {"Citation": "B\u0119benek E., Jastrz\u0119bska M., Kadela-Tomanek M., Chrobak E., Orzechowska B., Zwoli\u0144ska K., Latocha M., Mertas A., Czuba Z., Boryczka S. Novel triazole hybrids of betulin: Synthesis and biological activity profile. Molecules. 2017;22:1876. doi: 10.3390/molecules22111876.", "ArticleIdList": ["10.3390/molecules22111876", "PMC6150379", "29104263"]}, {"Citation": "Zhu R.X., Zhao L., Zhang Y.K., Luo P., Liu S.H., Wang J.G. Sequential treatment with ursolic acid chlorophenyl triazole followed by 5-fluorouracil shows synergistic activity in small cell lung cancer cells. Bangladesh J. Pharmacol. 2015;10:197\u2013204. doi: 10.3329/bjp.v10i1.21641.", "ArticleIdList": ["10.3329/bjp.v10i1.21641"]}, {"Citation": "Wei G., Luan W., Wang S., Cui S., Li F., Liu Y., Liu Y., Cheng M. A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: Design, synthesis, and biological evaluation. Org. Biomol. Chem. 2015;13:1507\u20131514. doi: 10.1039/C4OB01605J.", "ArticleIdList": ["10.1039/C4OB01605J", "25476168"]}, {"Citation": "Li F., Liu Y., Wang S., Wei G., Cheng M. Synthesis and tumor cytotoxicity of novel 1, 2, 3-triazole-substituted 3-oxo-oleanolic acid derivatives. Chem. Res. Chin. Univ. 2016;32:938\u2013942. doi: 10.1007/s40242-016-6301-5.", "ArticleIdList": ["10.1007/s40242-016-6301-5"]}, {"Citation": "Leal A.S., Wang R., Salvador J.A., Jing Y. Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cells. Bioorg. Med. Chem. 2012;20:5774\u20135786. doi: 10.1016/j.bmc.2012.08.010.", "ArticleIdList": ["10.1016/j.bmc.2012.08.010", "22959527"]}, {"Citation": "Pertino M.W., Lopez C., Theoduloz C., Schmeda-Hirschmann G. 1,2,3-Triazole-substituted oleanolic acid derivatives: Synthesis and antiproliferative activity. Molecules. 2013;18:7661. doi: 10.3390/molecules18077661.", "ArticleIdList": ["10.3390/molecules18077661", "PMC6270232", "23884119"]}, {"Citation": "Lakshmi J.K., Pattnaik B., Kavitha R., Mallavadhani U.V., Jagadeesh B. Conformation of flexibly linked triterpene dimers by using RDC-enhanced NMR spectroscopy. J. Mol. Struct. 2018;1162:26\u201330. doi: 10.1016/j.molstruc.2018.02.083.", "ArticleIdList": ["10.1016/j.molstruc.2018.02.083"]}, {"Citation": "Pattnaik B., Lakshmi J.K., Kavitha R., Jagadeesh B., Bhattacharjee D., Jain N., Mallavadhani U.V. Synthesis, structural studies, and cytotoxic evaluation of novel ursolic acid hybrids with capabilities to arrest breast cancer cells in mitosis. J. Asian Nat. Prod. Res. 2017;19:260\u2013271. doi: 10.1080/10286020.2016.1240169.", "ArticleIdList": ["10.1080/10286020.2016.1240169", "27762142"]}, {"Citation": "Popov S.A., Semenova M.D., Baev D.S., Frolova T.S., Shestopalov M.A., Wang C., Qi Z., Shults E.E., Turks M. Synthesis and cytotoxicity of hybrids of 1, 3, 4-or 1, 2, 5-oxadiazoles tethered from ursane and lupane core with 1, 2, 3-triazole. Steroids. 2020;162:108698. doi: 10.1016/j.steroids.2020.108698.", "ArticleIdList": ["10.1016/j.steroids.2020.108698", "32687846"]}, {"Citation": "Rashid S., Dar B.A., Majeed R., Hamid A., Bhat B.A. Synthesis and biological evaluation of ursolic acid-triazolyl derivatives as potential anti-cancer agents. Eur. J. Med. Chem. 2013;66:238\u2013245. doi: 10.1016/j.ejmech.2013.05.029.", "ArticleIdList": ["10.1016/j.ejmech.2013.05.029", "23811086"]}, {"Citation": "Fustero S., Sanchez-Rosello M., Barrio P., Simon-Fuentes A. From 2000 to mid-2010: A fruitful decade for the synthesis of pyrazoles. Chem. Rev. 2011;111:6984\u20137034. doi: 10.1021/cr2000459.", "ArticleIdList": ["10.1021/cr2000459", "21806021"]}, {"Citation": "Karrouchi K., Radi S., Ramli Y., Taoufik J., Mabkhot Y.N., Al-Aizari F.A. Synthesis and pharmacological activities of pyrazole derivatives: A review. Molecules. 2018;23:134. doi: 10.3390/molecules23010134.", "ArticleIdList": ["10.3390/molecules23010134", "PMC6017056", "29329257"]}, {"Citation": "Ansari A., Ali A., Asif M. Biologically active pyrazole derivatives. New J. Chem. 2017;41:16\u201341. doi: 10.1039/C6NJ03181A.", "ArticleIdList": ["10.1039/C6NJ03181A"]}, {"Citation": "Balbi A., Anzaldi M., Macci\u00f2 C., Aiello C., Mazzei M., Gangemi R., Castagnola P., Miele M., Rosano C., Viale M. Synthesis and biological evaluation of novel pyrazole derivatives with anticancer activity. Eur. J. Med. Chem. 2011;46:5293\u20135309. doi: 10.1016/j.ejmech.2011.08.014.", "ArticleIdList": ["10.1016/j.ejmech.2011.08.014", "21920636"]}, {"Citation": "Puneeth H.R., Ananda H., Kumar K.S.S., Rangappa K.S., Sharada A.C. Synthesis and antiproliferative studies of curcumin pyrazole derivatives. Med. Chem. Res. 2016;25:1842\u20131851. doi: 10.1007/s00044-016-1628-5.", "ArticleIdList": ["10.1007/s00044-016-1628-5"]}, {"Citation": "Ravula P., Vamaraju H.B., Paturi M., JN N.S.C., Kolli S. Design, synthesis, in silico toxicity prediction, molecular docking, and evaluation of novel pyrazole derivatives as potential antiproliferative agents. EXCLI J. 2016;15:187.", "ArticleIdList": ["PMC4834670", "27103897"]}, {"Citation": "Nitulescu G.M., Draghici C., Missir A.V. Synthesis of new pyrazole derivatives and their anticancer evaluation. Eur. J. Med. Chem. 2010;45:4914\u20134919. doi: 10.1016/j.ejmech.2010.07.064.", "ArticleIdList": ["10.1016/j.ejmech.2010.07.064", "20728965"]}, {"Citation": "Insuasty B., Tigreros A., Orozco F., Quiroga J., Abon\u00eda R., Nogueras M., Sanchez A., Cobo J. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4, 5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents. Bioorg. Med. Chem. 2010;18:4965\u20134974. doi: 10.1016/j.bmc.2010.06.013.", "ArticleIdList": ["10.1016/j.bmc.2010.06.013", "20594863"]}, {"Citation": "Labbozzetta M., Baruchello R., Marchetti P., Gueli M.C., Poma P., Notarbartolo M., Simoni D., D\u2019Alessandro N. Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities hem. Biol. Interact. 2009;181:29\u201336. doi: 10.1016/j.cbi.2009.06.005.", "ArticleIdList": ["10.1016/j.cbi.2009.06.005", "19539615"]}, {"Citation": "Bennani F.E., Doudach L., Cherrah Y., Ramli Y., Karrouchi K., Faouzi M.E.A. Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line. Bioorg. Chem. 2020;97:103470. doi: 10.1016/j.bioorg.2019.103470.", "ArticleIdList": ["10.1016/j.bioorg.2019.103470", "32120072"]}, {"Citation": "Sun L., Li B., Su X., Chen G., Li Y., Yu L., Li L., Wei W. An ursolic acid derived small molecule triggers cancer cell death through hyperstimulation of macropinocytosis. J. Med. Chem. 2017;60:6638\u20136648. doi: 10.1021/acs.jmedchem.7b00592.", "ArticleIdList": ["10.1021/acs.jmedchem.7b00592", "28678485"]}, {"Citation": "Li W., Zhang H., Nie M., Wang W., Liu Z., Chen C., Chen H., Liu R., Baloch Z., Ma K. A novel synthetic ursolic acid derivative inhibits growth and induces apoptosis in breast cancer cell lines. Oncol. Lett. 2018;15:2323\u20132329. doi: 10.3892/ol.2017.7578.", "ArticleIdList": ["10.3892/ol.2017.7578", "PMC5776946", "29434940"]}, {"Citation": "Chen Y., Li C., Zheng Y., Gao Y., Hu J., Chen H. Discovery of FZU-03,010 as a self-assembling anticancer amphiphile for acute myeloid leukemia. Bioorg. Med. Chem. Lett. 2017;27:1007\u20131011. doi: 10.1016/j.bmcl.2016.12.071.", "ArticleIdList": ["10.1016/j.bmcl.2016.12.071", "28073673"]}, {"Citation": "Santos R.C., Salvador J.A., Cort\u00e9s R., Pach\u00f3n G., Mar\u00edn S., Cascante M. New betulinic acid derivatives induce potent and selective antiproliferative activity through cell cycle arrest at the S phase and caspase dependent apoptosis in human cancer cells. Biochimie. 2011;93:1065\u20131075. doi: 10.1016/j.biochi.2011.02.014.", "ArticleIdList": ["10.1016/j.biochi.2011.02.014", "21377507"]}, {"Citation": "Leal A.S., Wang R., Salvador J.A., Jing Y. Synthesis of novel heterocyclic oleanolic acid derivatives with improved antiproliferative activity in solid tumor cells. Org. Biomol. Chem. 2013;11:1726\u20131738. doi: 10.1039/c3ob00011g.", "ArticleIdList": ["10.1039/c3ob00011g", "23381885"]}, {"Citation": "Han Y., Dong W., Guo Q., Li X., Huang L. The importance of indole and azaindole scaffold in the development of antitumor agents. Eur. J. Med. Chem. 2020:112506. doi: 10.1016/j.ejmech.2020.112506.", "ArticleIdList": ["10.1016/j.ejmech.2020.112506", "32688198"]}, {"Citation": "Khusnutdinova E.F., Petrova A.V., Apryshko G.N., Kukovinets O.S., Kazakova O.B. Synthesis and cytotoxicity of indole derivatives of betulin, erythrodiol, and uvaol. Russ. J. Bioorg. Chem. 2018;44:322\u2013329. doi: 10.1134/S1068162018030081.", "ArticleIdList": ["10.1134/S1068162018030081"]}, {"Citation": "Khusnutdinova E.F., Petrova A.V., Kukovinets O.S., Kazakova O.B. Synthesis and cytotoxicity of 28-N-propargylaminoalkylated 2,3-indolotriterpenic acids. Nat. Prod. Commun. 2018;13:1934578X1801300603. doi: 10.1177/1934578X1801300603.", "ArticleIdList": ["10.1177/1934578X1801300603"]}, {"Citation": "Tang K., Huang J., Pan J., Zhang X., Lu W. Design, synthesis and biological evaluation of C (6)-indole celastrol derivatives as potential antitumor agents. RSC Adv. 2015;5:19620\u201319623. doi: 10.1039/C4RA15414B.", "ArticleIdList": ["10.1039/C4RA15414B"]}, {"Citation": "Fan H., Geng L., Yang F., Dong X., He D., Zhang Y. Ursolic acid derivative induces apoptosis in glioma cells through down-regulation of cAMP. Eur. J. Med. Chem. 2019;176:61\u201367. doi: 10.1016/j.ejmech.2019.04.059.", "ArticleIdList": ["10.1016/j.ejmech.2019.04.059", "31096119"]}, {"Citation": "Walayat K., Mohsin N.U.A., Aslam S., Ahmad M. An insight into the therapeutic potential of piperazine-based anticancer agents. Turkish J. Chem. 2019;43:1\u201323. doi: 10.3906/kim-1806-7.", "ArticleIdList": ["10.3906/kim-1806-7"]}, {"Citation": "Rathi A.K., Syed R., Shin H.S., Patel R.V. Piperazine derivatives for therapeutic use: A patent review (2010-present) Expert Opin. Ther. Pat. 2016;26:777\u2013797. doi: 10.1080/13543776.2016.1189902.", "ArticleIdList": ["10.1080/13543776.2016.1189902", "27177234"]}, {"Citation": "Zhao C.H., Zhang C.L., Shi J.J., Hou X.Y., Feng B., Zhao L.X. Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents. Bioorg. Med. Chem. Lett. 2015;25:4500\u20134504. doi: 10.1016/j.bmcl.2015.08.076.", "ArticleIdList": ["10.1016/j.bmcl.2015.08.076", "26343825"]}, {"Citation": "Yamansarov E.Y., Osterman I.A., Komarova E.S., Skvortsov D.A., Saltikova I.V., Majouga A.G., Ivanenkov Y.A., Giniyatullina G.V., Kazakova O.B., Baikova I.P. Synthesis and cytotoxicity of a-azepanobetulinic acid N-methyl-piperazinylamide. Nat. Prod. Commun. 2019;14 doi: 10.1177/1934578X19860670.", "ArticleIdList": ["10.1177/1934578X19860670"]}, {"Citation": "Hua S.X., Huang R.Z., Ye M.Y., Pan Y.M., Yao G.Y., Zhang Y., Wang H.S. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents. Eur. J. Med. Chem. 2015;95:435\u2013452. doi: 10.1016/j.ejmech.2015.03.051.", "ArticleIdList": ["10.1016/j.ejmech.2015.03.051", "25841199"]}, {"Citation": "Liu M.C., Yang S.J., Jin L.H., Hu D.Y., Xue W., Song B.A., Yang S. Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety. Eur. J. Med. Chem. 2012;58:128\u2013135. doi: 10.1016/j.ejmech.2012.08.048.", "ArticleIdList": ["10.1016/j.ejmech.2012.08.048", "23124210"]}, {"Citation": "Wang W., Lei L., Liu Z., Wang H., Meng Q. Design, synthesis, and biological evaluation of novel nitrogen heterocycle-containing ursolic acid analogs as antitumor agents. Molecules. 2019;24:877. doi: 10.3390/molecules24050877.", "ArticleIdList": ["10.3390/molecules24050877", "PMC6429512", "30832266"]}, {"Citation": "Kahnt M., Hoenke S., Fischer L., Al-Harrasi A., Csuk R. Synthesis and cytotoxicity evaluation of DOTA-conjugates of ursolic acid. Molecules. 2019;24:2254. doi: 10.3390/molecules24122254.", "ArticleIdList": ["10.3390/molecules24122254", "PMC6630699", "31212958"]}, {"Citation": "Choudhary S., Singh P.K., Verma H., Singh H., Silakari O. Success stories of natural product-based hybrid molecules for multi-factorial diseases. Eur. J. Med. Chem. 2018;151:62\u201397. doi: 10.1016/j.ejmech.2018.03.057.", "ArticleIdList": ["10.1016/j.ejmech.2018.03.057", "29605809"]}, {"Citation": "Brand\u00e3o G.C., Missias F.C.R., Arantes L.M., Soares L.F., Roy K.K., Doerksen R.J., de Oliveira A.B., Pereira G.R. Antimalarial naphthoquinones. Synthesis via click chemistry, in vitro activity, docking to PfDHODH and SAR of lapachol-based compounds. Eur. J. Med. Chem. 2018;145:191\u2013205. doi: 10.1016/j.ejmech.2017.12.051.", "ArticleIdList": ["10.1016/j.ejmech.2017.12.051", "29324340"]}, {"Citation": "Sommerwerk S., Heller L., Kuhfs J., Csuk R. Selective killing of cancer cells with triterpenoic acid amides-The substantial role of an aromatic moiety alignment. Eur. J. Med. Chem. 2016;122:452\u2013464. doi: 10.1016/j.ejmech.2016.06.053.", "ArticleIdList": ["10.1016/j.ejmech.2016.06.053", "27416552"]}, {"Citation": "Hoenke S., Heise N.V., Kahnt M., Deigner H.P., Csuk R. Betulinic acid derived amides are highly cytotoxic, apoptotic and selective. Eur. J. Med. Chem. 2020;207:112815. doi: 10.1016/j.ejmech.2020.112815.", "ArticleIdList": ["10.1016/j.ejmech.2020.112815", "32956968"]}, {"Citation": "Kadela-Tomanek M., B\u0119benek E., Chrobak E., Marciniec K., Latocha M., Ku\u015bmierz D., Jastrz\u0119bska M., Boryczka S. Betulin-1, 4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme. Eur. J. Med. Chem. 2019;177:302\u2013315. doi: 10.1016/j.ejmech.2019.05.063.", "ArticleIdList": ["10.1016/j.ejmech.2019.05.063", "31158746"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "11", "Day": "14"}, {"Year": "2020", "Month": "11", "Day": "28"}, {"Year": "2020", "Month": "11", "Day": "29"}, {"Year": "2021", "Month": "4", "Day": "30", "Hour": "1", "Minute": "11"}, {"Year": "2021", "Month": "5", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["33918996", "PMC8122576", "10.3390/molecules26092401", "molecules26092401"]}}], "PubmedBookArticle": []}